Done sou Salè H1B

Akèy › Anplwayè › Vertex Pharmaceuticals Incorporated › Health Economics & Outcomes Research Senior Manager

Health Economics & Outcomes Research Senior Manager nan Vertex Pharmaceuticals Incorporated: Salè H-1B

6 aplikasyon kondisyon travay pou tit travay Health Economics & Outcomes Research Senior Manager nan Vertex Pharmaceuticals Incorporated. Salè baz medyàn ofri $141,916; mwatye mitan $138,338–$143,896.

Demann (LCA)6
Salè medyan ofri$141,916
Mwatye salè yo$138,338–$143,896
10yèm–90yèm pousantaj$136,850–$148,500

Pa ane fiskal

Ane fiskalLCASalè medyan
FY20231$140,250
FY20241$136,000
FY20252$140,641
FY20262$148,500

Aplikasyon

Salè bazKoteSoumètDat kòmansmanEstati
$144,000–$216,000
Nivo IV
Boston, MADec 24, 2025Jan 26, 2026Certifye
$153,000–$207,000
Nivo III
Boston, MASep 30, 2025Oct 20, 2025Certifye
$137,700–$186,300
Nivo IV
Boston, MAJun 18, 2025Jun 24, 2025Certifye
$143,582–$194,258
Nivo III
Boston, MADec 11, 2024Jun 6, 2025Certifye
$136,000–$184,000
Nivo III
Boston, MAMay 2, 2024May 9, 2024Certifye
$140,250–$189,750
Nivo IV
Ann Arbor, MINov 8, 2022Nov 28, 2022Certifye

Lòt travay nan Vertex Pharmaceuticals Incorporated

Salè yo se fen ki pi ba nan salè yo ofri sou chak aplikasyon, konvèti nan yon montan anyèl; estatistik yo itilize sèlman aplikasyon tan plen sètifye. Yon LCA pa yon apwobasyon visa epi yon sèl LCA ka kouvri plizyè pozisyon. Sous: Depatman Travay Etazini, Done Divulgasyon LCA OFLC, ane fiskal 2023–2026 (dènye desizyon Jun 30, 2026).